Published in Acta Neurol Scand on July 01, 2004
Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry (2005) 2.35
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler (2015) 1.80
Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychol Health Med (2009) 1.36
Patient and caregiver quality of life in Huntington's disease. Mov Disord (2008) 1.29
The benefits of exercise training in multiple sclerosis. Nat Rev Neurol (2012) 1.21
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler (2015) 1.18
Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis. Health Qual Life Outcomes (2008) 1.11
Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health Qual Life Outcomes (2005) 1.09
High concurrent presence of disability in multiple sclerosis. Associations with perceived health. J Neurol (2007) 1.09
Relationship of depression, disability, and family caregiver attitudes to the quality of life of Kuwaiti persons with multiple sclerosis: a controlled study. BMC Neurol (2007) 1.02
The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis. Ann Indian Acad Neurol (2008) 1.02
Characterization of functioning in multiple sclerosis using the ICF. J Neurol (2010) 1.02
Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes (2006) 1.01
Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. Psychiatry Res (2010) 1.01
A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol (2006) 1.00
Cognitive dysfunction in pediatric multiple sclerosis. Neuropsychiatr Dis Treat (2014) 0.99
Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabil Psychol (2014) 0.99
The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes (2009) 0.99
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Mult Scler Int (2013) 0.97
Quality of life in multiple sclerosis. J Med Life (2011) 0.97
Poor sleep in patients with multiple sclerosis. PLoS One (2012) 0.95
Depression in multiple sclerosis: a longitudinal analysis. Arch Psychiatr Nurs (2007) 0.94
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord (2011) 0.94
Life issues in multiple sclerosis. Nat Rev Neurol (2010) 0.90
The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference. J Neurol (2011) 0.89
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler (2014) 0.89
Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS). Health Qual Life Outcomes (2010) 0.88
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci (2007) 0.88
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment. Mult Scler Int (2014) 0.87
A comparative study of pelvic floor muscle training in women with multiple sclerosis: its impact on lower urinary tract symptoms and quality of life. Clinics (Sao Paulo) (2011) 0.87
Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis. Iran J Neurol (2013) 0.84
Fatigue in multiple sclerosis: a look at the role of poor sleep. Front Neurol (2015) 0.84
Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis. Int J Prev Med (2014) 0.82
Sleep disturbances in patients with multiple sclerosis. Neurol Sci (2012) 0.81
Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis. Int J MS Care (2015) 0.81
Validation of mood measures for people with multiple sclerosis. Int J MS Care (2014) 0.80
Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review. ASN Neuro (2014) 0.80
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation. Front Cell Neurosci (2015) 0.79
The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study. Indian J Palliat Care (2016) 0.78
Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life. J Neurosci Rural Pract (2013) 0.78
Effects of Single Bouts of Walking Exercise and Yoga on Acute Mood Symptoms in People with Multiple Sclerosis. Int J MS Care (2016) 0.78
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression. Rehabil Res Pract (2014) 0.77
Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis. J Neurol (2011) 0.77
Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients. Eur Arch Otorhinolaryngol (2010) 0.77
Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue. J Neurosci Rural Pract (2013) 0.77
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society. Acta Neurol Scand (2016) 0.76
Comparison of self-report sleep measures for individuals with multiple sclerosis and spinal cord injury. Arch Phys Med Rehabil (2014) 0.76
Poor sleep quality in patients with multiple sclerosis: gender differences. Brain Behav (2016) 0.75
Social characteristics and quality of life of portuguese multiple sclerosis patients. Neurol Ther (2013) 0.75
Multiple Sclerosis Patients Valuing Their Own Health Status: Valuation and Psychometric Properties of the 15D. Neurol Int (2016) 0.75
Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life. PLoS One (2015) 0.75
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis. Rehabil Res Pract (2015) 0.75
Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE. Ther Adv Neurol Disord (2016) 0.75
Depression in multiple sclerosis. Acta Neurol Scand (2005) 0.75
Depression as a predictor of occupational transition in a multiple sclerosis cohort. Funct Neurol (2014) 0.75
The rights of persons with disability bill, 2014: Implications for neurological disability. Ann Indian Acad Neurol (2016) 0.75
In-person and online social participation and emotional health in individuals with multiple sclerosis. Qual Life Res (2017) 0.75
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs. CNS Drugs (2017) 0.75
What explains functioning from the perspective of people with multiple sclerosis? J Neurol (2014) 0.75
The relationship between fatigability and sleep quality in people with multiple sclerosis. Mult Scler J Exp Transl Clin (2016) 0.75
Randomized controlled trial of exercise interventions to improve sleep quality and daytime sleepiness in individuals with multiple sclerosis: A pilot study. Mult Scler J Exp Transl Clin (2016) 0.75
Capturing saccades in multiple sclerosis with a digitized test of rapid number naming. J Neurol (2017) 0.75
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93
The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful. Clin Microbiol Infect (2014) 2.62
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol (1992) 2.19
Is Hodgkin's disease a human counterpart of bacterially induced crown-gall tumours? Lancet (1995) 2.00
Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics (1996) 1.98
Interferon in human serum after injection of endotoxin. Lancet (1980) 1.95
A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol (1994) 1.81
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging (2006) 1.79
Bone marrow derived elements and resident microglia in brain inflammation. Glia (1993) 1.78
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol (1986) 1.77
Sleep spindle-related activity in the human EEG and its relation to general cognitive and learning abilities. Eur J Neurosci (2006) 1.63
Association of the class V myosin Myo4p with a localised messenger RNA in budding yeast depends on She proteins. J Cell Sci (1999) 1.55
European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr (1996) 1.51
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci (2011) 1.49
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. Eur J Cancer Clin Oncol (1989) 1.48
Occurrence of Andermann syndrome out of French Canada--agenesis of the corpus callosum with neuronopathy. Neuropediatrics (1993) 1.46
Low-resolution brain electromagnetic tomography revealed simultaneously active frontal and parietal sleep spindle sources in the human cortex. Neuroscience (2001) 1.43
Phase I/II study of liposome-complexed mitoxantrone in patients with advanced breast cancer. Ann Oncol (1992) 1.41
Interrater reliability between scorers from eight European sleep laboratories in subjects with different sleep disorders. J Sleep Res (2004) 1.33
Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet (1985) 1.32
Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology (2005) 1.28
The evolution of menopausal symptoms. Baillieres Clin Endocrinol Metab (1993) 1.26
Depletion of a microtubule-associated motor protein induces the loss of dendritic identity. J Neurosci (2000) 1.26
Experimental arthritis induced by granulocyte collagenase. Scand J Rheumatol (1980) 1.25
Naturally occurring deuterium is essential for the normal growth rate of cells. FEBS Lett (1993) 1.23
Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler Thromb Vasc Biol (1995) 1.22
Topographic distribution of sleep spindles in young healthy subjects. J Sleep Res (1997) 1.22
Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol (2006) 1.20
A sulfate pocket formed by three GoU pairs in the 0.97 A resolution X-ray structure of a nonameric RNA. RNA (1999) 1.20
Characteristics of smokers who attempt to quit and of those who recently succeeded. Am J Prev Med (1995) 1.17
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (2011) 1.16
The SIESTA project polygraphic and clinical database. IEEE Eng Med Biol Mag (2001) 1.16
Progressive cerebellar syndrome in adult coeliac disease. J Neurol (1987) 1.14
Familial hemiplegic migraine: follow-up findings of diffusion-weighted magnetic resonance imaging (MRI), perfusion-MRI and [99mTc] HMPAO-SPECT in a patient with prolonged hemiplegic aura. Cephalalgia (2004) 1.13
Central nervous system function after cardiopulmonary bypass. Eur Heart J (1993) 1.13
Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev Neurol (Paris) (1991) 1.13
Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J Cereb Blood Flow Metab (1987) 1.11
Microglial cells are a component of the perivascular glia limitans. J Neurosci Res (1991) 1.09
Unilateral Creutzfeldt-Jakob disease. Neurology (1986) 1.08
Automatic sleep-spindle detection procedure: aspects of reliability and validity. Clin Electroencephalogr (1994) 1.08
Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Minim Invasive Neurosurg (2007) 1.07
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med (2000) 1.07
Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol (2009) 1.05
[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry (2001) 1.05
Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol (1991) 1.02
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci (2012) 1.02
Ultracytochemical distribution of myelin basic protein after injection into the cerebrospinal fluid. Evidence for transport through the blood-brain barrier and binding to the luminal surface of cerebral veins. J Neurol Sci (1984) 1.01
Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl (1997) 1.01
[Double infection with early summer meningoencephalitis virus and Borrelia burgdorferi]. Dtsch Med Wochenschr (1986) 1.00
Fatal encephalitis in a patient with chronic graft-versus-host disease. Bone Marrow Transplant (1990) 0.99
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry (2001) 0.99
EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol (2006) 0.99
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain (2000) 0.98
[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord (2000) 0.98
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. Eur J Nucl Med Mol Imaging (2002) 0.97
European Lyme borreliosis. Ann N Y Acad Sci (1988) 0.96
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clin Pharmacol Ther (2012) 0.95
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. Eur J Nucl Med Mol Imaging (2002) 0.95
Human somatosensory cortical finger representation as studied by combined neuromagnetic and neuroelectric measurements. Neurosci Lett (1991) 0.94
Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome. J Sleep Res (2000) 0.93
Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology (2001) 0.93
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology (2001) 0.93
iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ Res (2000) 0.93
Adult coeliac disease and brainstem encephalitis. J Neurol Neurosurg Psychiatry (1988) 0.92
Expression of adhesion molecules and histocompatibility antigens at the blood-brain barrier. Brain Pathol (1991) 0.92
Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int (1990) 0.92
The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity. Brain Res (1994) 0.92
Neuromagnetic investigation of somatotopy of human hand somatosensory cortex. Exp Brain Res (1991) 0.92
Crystallization within agarose gel in microgravity improves the quality of thaumatin crystals. Acta Crystallogr D Biol Crystallogr (1999) 0.91
[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry (2000) 0.91
Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol (1988) 0.90
Cloning of a new mouse foetal beta-globin mRNA sequence. Nucleic Acids Res (1981) 0.90
A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients. Mult Scler (2008) 0.90
SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J Neurol (2000) 0.90
Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology (1993) 0.90
First-night-effects on generalized anxiety disorder (GAD)-based insomnia: laboratory versus home sleep recordings. Sleep (1996) 0.90
Sleeping habits in the Austrian population. Sleep Med (2002) 0.90
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect (1993) 0.89
SPECT and MR imaging in herpes simplex encephalitis. J Comput Assist Tomogr (1991) 0.89
Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med (2001) 0.89
Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study. Neurology (1997) 0.89
Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology (1997) 0.89
The differential diagnosis of foot lumps: 101 cases treated surgically in North Glasgow over 4 years. Ann R Coll Surg Engl (2007) 0.89
EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. J Neurol (2004) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region. Neurology (2001) 0.88